QTEX — Qtrex Quantum Share News
0.000.00%
- $105.98m
- $95.91m
- $0.29m
Brief: Inspira Technologies Signs Agreement To Conduct Clinical Study Of Blood Sensor
Brief: Inspira Technologies Agrees To Conduct Clinical Study Of HYLA Blood Sensor
Brief: Inspira Technologies Reports Third Quarter 2022 Financial Results
Inspira up on blood monitor distribution agreement with Innovimed
Has Signed An Exclusive Distribution Agreement For The Hyla Blood Sensor With Innovimed Sp. Z O.O
Brief: Inspira™ Technologies Oxy BHN Signs A Strategic Agreement In Europe To Potentially Provide $26.1 For Deployment Of 1,364 Hyla™ Blood Sensors
Brief: Inspiratm Technologies Granted Patent By The Israeli Patent Office
Brief: Inspira Technologies Reports Second Quarter 2022 Financial Results
Brief: Inspira Technologies Oxy Bhn Ltd Files For Mixed Shelf Of Up To $50 Million – SEC Filing
Board Resolved To Appoint Yafit Tehila As Chief Financial Officer
Brief: Inspira™ Technologies Signs Strategic Agreement In U.S. To Potentially Provide $59 Million For Inspira For Deployment Of HYLA Blood Sensors
Inspira Technologies doubles on new blood monitor development
Revealed Development Of Hyla Blood Sensor
Brief: Inspira Technologies Oxy Bhn Ltd says Net Loss For The Three Months Ended March 31, 2022 Was $1.3 Million
Brief: Inspira Technologies Announces Deployment Agreement In The Israeli Market To Target $15M
Brief: Inspira Tech Releases Q4 Results
Inspira Tech leaps on signing U.S. distribution agreement
U.S. STOCKS ON THE MOVE-Netflix, Boeing, Ocuphire Pharma
Brief: Inspira Technologies Signs Strategic Agreement In The U.S. To Target $212 Million For Inspira Over A 7-Year Period